Literature DB >> 18713323

Phenotypic variability in Caucasian and Japanese patients with matched LQT1 mutations.

Judy F Liu1, Ilan Goldenberg, Arthur J Moss, Wataru Shimizu, Arthur A Wilde, Nynke Hofman, Scott McNitt, Wojciech Zareba, Yoshihiro Miyamato, Jennifer L Robinson, Mark L Andrews.   

Abstract

BACKGROUND: Ethnic differences may affect the phenotypic expression of genetic disorders. However, data regarding the effect of ethnicity on outcome in patients with genetic cardiac disorders are limited. We compared the clinical course of Caucasian and Japanese long QT type-1 (LQT1) patients who were matched for mutations in the KCNQ1 gene.
METHODS: The study population comprised 62 Caucasian and 38 Japanese LQT1 patients from the International LQTS Registry who were identified as having six identical KCNQ1 mutations. The biophysical function of the mutations was categorized into dominant-negative (> 50%) or haploinsufficiency (< or =50%) reduction in cardiac repolarizing IKs potassium channel current. The primary end point of the study was the occurrence of a first cardiac event from birth through age 40 years.
RESULTS: Japanese patients had a significantly higher cumulative rate of cardiac events (67%) than Caucasian patients (39%; P = 0.01). The respective frequencies of dominant negative mutations in the two ethnic groups were 63% and 28% (P < 0.001). In multivariate analysis, Japanese patients had an 81% increase in the risk of cardiac events (P = 0.06) as compared with Caucasians. However, when the biophysical function of the mutations was included in the multivariate model, the risk associated with Japanese ethnicity was no longer evident (HR = 1.05; P = 0.89). Harboring a dominant negative mutation was shown to be the most powerful and significant predictor of outcome (HR = 3.78; P < 0.001).
CONCLUSIONS: Our data indicate that ethnic differences in the clinical expression of LQTS can be attributed to the differences in frequencies of the specific mutations within the two populations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18713323      PMCID: PMC2538575          DOI: 10.1111/j.1542-474X.2008.00226.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  27 in total

1.  Mutation in KCNQ1 that has both recessive and dominant characteristics.

Authors:  A Murray; F Potet; C Bellocq; I Baró; W Reardon; H E Hughes; S Jeffery
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

2.  Molecular characterization of two founder mutations causing long QT syndrome and identification of compound heterozygous patients.

Authors:  Heidi Fodstad; Saïd Bendahhou; Jean-Sébastien Rougier; Päivi J Laitinen-Forsblom; Jacques Barhanin; Hugues Abriel; Laurent Schild; Kimmo Kontula; Heikki Swan
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

3.  Gender and age effects on ventricular repolarization abnormality in Japanese general carriers of a G643S common single nucleotide polymorphism for the KCNQ1 gene.

Authors:  Tomoya Ozawa; Makoto Ito; Shinji Tamaki; Takenori Yao; Takashi Ashihara; Yoshikuni Kita; Tomonori Okamura; Hirotsugu Ueshima; Minoru Horie
Journal:  Circ J       Date:  2006-06       Impact factor: 2.993

4.  Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3.

Authors:  Lisa B Cronk; Bin Ye; Toshihiko Kaku; David J Tester; Matteo Vatta; Jonathan C Makielski; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2006-12-06       Impact factor: 6.343

5.  Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2.

Authors:  I Splawski; J Shen; K W Timothy; M H Lehmann; S Priori; J L Robinson; A J Moss; P J Schwartz; J A Towbin; G M Vincent; M T Keating
Journal:  Circulation       Date:  2000-09-05       Impact factor: 29.690

Review 6.  The long QT syndrome: therapeutic implications of a genetic diagnosis.

Authors:  Wataru Shimizu
Journal:  Cardiovasc Res       Date:  2005-08-15       Impact factor: 10.787

7.  A common SCN5A polymorphism attenuates a severe cardiac phenotype caused by a nonsense SCN5A mutation in a Chinese family with an inherited cardiac conduction defect.

Authors:  Dau-Ming Niu; Betau Hwang; Han-Wei Hwang; Nana H Wang; Jer-Yuarn Wu; Pi-Chang Lee; Jen-Chung Chien; Ru-Chi Shieh; Yuan-Tsong Chen
Journal:  J Med Genet       Date:  2006-05-17       Impact factor: 6.318

8.  Evidence for a single nucleotide polymorphism in the KCNQ1 potassium channel that underlies susceptibility to life-threatening arrhythmias.

Authors:  T Kubota; M Horie; M Takano; H Yoshida; K Takenaka; E Watanabe; T Tsuchiya; H Otani; S Sasayama
Journal:  J Cardiovasc Electrophysiol       Date:  2001-11

9.  Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene.

Authors:  Arthur J Moss; Wataru Shimizu; Arthur A M Wilde; Jeffrey A Towbin; Wojciech Zareba; Jennifer L Robinson; Ming Qi; G Michael Vincent; Michael J Ackerman; Elizabeth S Kaufman; Nynke Hofman; Rahul Seth; Shiro Kamakura; Yoshihiro Miyamoto; Ilan Goldenberg; Mark L Andrews; Scott McNitt
Journal:  Circulation       Date:  2007-04-30       Impact factor: 29.690

10.  Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome.

Authors:  Michael J Ackerman; David J Tester; Gregg S Jones; Melissa L Will; Christopher R Burrow; Mark E Curran
Journal:  Mayo Clin Proc       Date:  2003-12       Impact factor: 7.616

View more
  2 in total

Review 1.  Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter?

Authors:  Rashmi R Shah
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

2.  Association of Genetic and Clinical Aspects of Congenital Long QT Syndrome With Life-Threatening Arrhythmias in Japanese Patients.

Authors:  Wataru Shimizu; Hisaki Makimoto; Kenichiro Yamagata; Tsukasa Kamakura; Mitsuru Wada; Koji Miyamoto; Yuko Inoue-Yamada; Hideo Okamura; Kohei Ishibashi; Takashi Noda; Satoshi Nagase; Aya Miyazaki; Heima Sakaguchi; Isao Shiraishi; Takeru Makiyama; Seiko Ohno; Hideki Itoh; Hiroshi Watanabe; Kenshi Hayashi; Masakazu Yamagishi; Hiroshi Morita; Masao Yoshinaga; Yoshiyasu Aizawa; Kengo Kusano; Yoshihiro Miyamoto; Shiro Kamakura; Satoshi Yasuda; Hisao Ogawa; Toshihiro Tanaka; Naotaka Sumitomo; Nobuhisa Hagiwara; Keiichi Fukuda; Satoshi Ogawa; Yoshifusa Aizawa; Naomasa Makita; Tohru Ohe; Minoru Horie; Takeshi Aiba
Journal:  JAMA Cardiol       Date:  2019-03-01       Impact factor: 14.676

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.